HTR3C

5-hydroxytryptamine receptor 3C (5-HT3-C) (5- · Q8WXA8 · HTR3C on Sugi Atlas →

67,765 patent compounds predicted against HTR3C, 45,107 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Tropisetron Tropisetron (SCHEMBL18297) 1.00 7/20
Tropisetron Tropisetron (SCHEMBL18299) 1.00 7/20
Tropisetron Tropisetron (SCHEMBL133873) 0.98 7/20
Dolasetron Dolasetron (SCHEMBL42063) 0.72 7/20
Dolasetron Dolasetron (SCHEMBL42064) 0.72 7/20
Dolasetron Dolasetron (SCHEMBL42065) 0.72 7/20
Dolasetron Dolasetron (SCHEMBL41145) 0.65 7/20
Dolasetron Dolasetron (SCHEMBL41146) 0.65 7/20
Mirisetron Mirisetron (SCHEMBL194840) 0.59 7/20
Mirisetron Mirisetron (SCHEMBL194841) 0.59 7/20
Mirisetron Mirisetron (SCHEMBL121861) 0.55 6/20
Mirisetron Mirisetron (SCHEMBL121862) 0.55 6/20
Phenylpiperazine Phenylpiperazine (SCHEMBL24889) 1.00 5/20
Phenylpiperazine Phenylpiperazine (SCHEMBL55125) 1.00 5/20
SCHEMBL166140 SCHEMBL166140 1.00 5/20
SCHEMBL232655 SCHEMBL232655 0.61 5/20
SCHEMBL59331 SCHEMBL59331 0.61 5/20
SCHEMBL164098 SCHEMBL164098 0.56 5/20
SCHEMBL221254 SCHEMBL221254 0.55 5/20
Noxiptiline Noxiptiline (SCHEMBL49824) 0.52 5/20

Clinical trials — most relevant to HTR3C by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Medication, Weight Gain and GI Hormones PHASE4COMPLETED
Cariprazine Versus Placebo for Social Anxiety Disorder PHASE4COMPLETED
Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder PHASE4NOT_YET_RECRUITING
Clinical Neurobiology of Serotonin and Addiction PHASE2/PHASE3COMPLETED
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms PHASE3COMPLETED
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone PHASE3COMPLETED
5HT2CR Balance in Brain Connectivity in Cocaine Dependence PHASE1/PHASE2COMPLETED
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET PHASE1/PHASE2COMPLETED
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression PHASE1/PHASE2RECRUITING
Lorcaserin Intra Venous Cocaine Effects PHASE1/PHASE2UNKNOWN
Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease PHASE2COMPLETED
Buspirone, Stress, and Attentional Bias to Marijuana Cues PHASE2COMPLETED
The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting PHASE2COMPLETED
The Neurobiological Effect of 5-HT2AR Modulation PHASE1RECRUITING
PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY PHASE1COMPLETED
The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling nanUNKNOWN
The Efficacy of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery. nanCOMPLETED
Intern Health Study nanENROLLING_BY_INVITATION
Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors nanCOMPLETED
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers nanCOMPLETED
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma nanACTIVE_NOT_RECRUITING
Epigenetic and Neurochemical Correlates of Bipolar Disorder nanNOT_YET_RECRUITING
PET Whole Body Distribution Studies Using [11C]CUMI nanCOMPLETED
Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder nanWITHDRAWN
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis nanCOMPLETED
Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome nanCOMPLETED
Investigating the Neuropsychological Effects of 5-HT2a Antagonism nanRECRUITING
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke nanCOMPLETED
The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HTR3C binder may also engage these)

ProteinNameSimilarity
HTR3E 5-hydroxytryptamine receptor 3E (5-HT3-E) (5- 0.991 landscape →
HTR3A 5-hydroxytryptamine receptor 3A 0.983 landscape →
P23979 0.981 P23979 →
O70212 0.979 O70212 →
P35563 0.975 P35563 →
HTR3B 5-hydroxytryptamine receptor 3B 0.960 landscape →
P13536 0.940 P13536 →
O97741 0.937 O97741 →
SCNN1A Epithelial sodium channel subunit alpha 0.937 landscape →
P04760 0.937 P04760 →
P25109 0.935 P25109 →
Q9JJ16 0.935 Q9JJ16 →
H2Q5A1 0.934 H2Q5A1 →
P09660 0.934 P09660 →
Q9JHJ5 0.933 Q9JHJ5 →
CHRNG Acetylcholine receptor subunit gamma 0.933 landscape →
CHRNB1 Acetylcholine receptor subunit beta 0.932 landscape →
P02715 0.932 P02715 →
P55270 0.932 P55270 →
P04758 0.931 P04758 →
P18916 0.931 P18916 →
CHRNE Acetylcholine receptor subunit epsilon 0.930 landscape →
P02713 0.930 P02713 →
Q9P0L9 0.930 Q9P0L9 →
P37089 0.929 P37089 →
P20782 0.928 P20782 →
A2A259 0.927 A2A259 →
Q9R1N2 0.926 Q9R1N2 →
Q61180 0.926 Q61180 →
P09690 0.926 P09690 →